Corporate Venture Capital Firms in the US

450 Ventures is the corporate venture arm of Blue Cross and Blue Shield of Alabama (BCBSAL) that makes strategic equity investments with an emphasis on health care and health-technology companies. The vehicle invests to advance BCBSAL’s strategic objectives while providing capital and operational partnership to high-growth startups in the health ecosystem.450 Ventures is headquartered in Birmingham, Alabama, and appears to focus on U.S. opportunities; third-party databases report a small, targeted portfolio (reported as four investments across health and adjacent software and mobile categories) rather than a broad, high-volume fund portfolio.The team is embedded with BCBSAL’s corporate functions and includes investment professionals and BCBSAL staff who source and manage deals; public listings identify BCBSAL personnel associated with 450 Ventures activity.

Adobe Ventures is the corporate venture capital arm of Adobe Inc., founded in 1994 and headquartered in San Jose, California. The firm focuses on investing in emerging technology companies that align strategically with Adobe's core business areas, including creativity, marketing, and artificial intelligence. It seeks both financial and strategic returns by supporting exceptional founders and teams shaping the future of personalized digital experiences.Adobe Ventures invests across seed, early-stage, and late-stage venture rounds, primarily targeting companies that develop innovative software, internet technologies, enterprise software, video platforms, and AI-powered solutions. The firm's portfolio includes companies engaged in technologies such as image generation through diffusion technology, enterprise AI video solutions, spatial intelligence, and AI-powered work platforms.The firm also cultivates close partnerships with its portfolio companies, offering capital, strategic partnerships, access to Adobe’s global ecosystem, advisory support, and invitations to significant Adobe events such as Adobe MAX and Adobe Summit. Over the next several years, Adobe Ventures plans to invest approximately $100 million in companies leveraging Adobe platform technologies, particularly those building applications on Adobe Integrated Runtime (AIR). Adobe Ventures is recognized for its deep strategic investing history and commitment to accelerating category-defining companies in the digital experience space.

AMD Ventures is the corporate venture capital arm of Advanced Micro Devices (AMD), headquartered in Santa Clara, California. As a global, multi‑stage investor, it partners with startups aligned to AMD’s vision of pervasive AI, next‑generation data‑center technologies, GPU/cloud infrastructure, silicon photonics, and emerging compute architectures. With AMD’s technical expertise, marketing reach, and ecosystem support, it aims to accelerate innovation across hardware and software domains. The fund invests in startups across horizontal and vertical AI platforms spanning life sciences, financial services, gaming, data center infrastructure, and core chip technologies including cooling and advanced packaging. Notable investments include Ayar Labs, Liquid AI, TensorWave, Cohere, Hugging Face, Luma AI, Celestial AI, Seekr, xAI, Vultr, and more—demonstrating strong activity especially throughout 2025. By selecting AMD Ventures, portfolio companies gain access to AMD’s deep technical talent pool, participation in marketing and PR programs, collaboration with ecosystem partners, and a long‑term commitment from a strategic corporate investor who “thinks in years, not months.

Amgen Ventures is the corporate venture capital arm of Amgen Inc., a global biotechnology leader dedicated to discovering, developing, and delivering innovative human therapeutics. Founded to support and collaborate with emerging companies in the life sciences space, Amgen Ventures focuses on early-stage investments that align with Amgen’s scientific and strategic priorities. The firm invests in startups that are pioneering novel therapies, platform technologies, and digital health solutions, with a strong emphasis on therapeutic areas such as oncology, inflammation, neuroscience, and cardiovascular diseases. Amgen Ventures brings more than funding—it offers strategic support, access to Amgen’s extensive scientific resources, and potential for long-term partnership opportunities. With a portfolio of promising biotech companies across North America and beyond, Amgen Ventures plays a critical role in fostering external innovation. The team operates with a collaborative mindset, helping startups advance their science while complementing Amgen’s mission to serve patients with serious illnesses.

Cisco Investments is the global corporate venture investment arm of Cisco Systems, established in 1993. With a strategic focus on innovation, Cisco Investments actively partners with startups and venture funds to identify and support emerging technologies that shape the future of enterprise IT, networking, and beyond. The organization invests hundreds of millions of dollars annually, maintaining a portfolio of over 100 active companies and more than 50 venture fund investments.The investment mandate spans both Cisco’s core markets and nascent industry segments, including AI, security, networking, sustainability, silicon & optics, cloud computing, and more. Cisco Investments is known for its unique approach, prioritizing strategic alignment and long-term value creation over purely financial returns. The team works closely with portfolio companies, offering access to Cisco’s global salesforce, technical expertise, and thought leadership to accelerate growth and market impact.Cisco Investments operates with a global footprint, maintaining offices in key technology hubs across North America, Asia, Europe, and the Middle East. Its approach extends beyond traditional venture capital, combining direct investments, fund partnerships, and strategic M&A to foster a collaborative ecosystem for innovation. Its recent launch of a $1 billion AI investment fund underscores its commitment to advancing secure, reliable, and trustworthy AI solutions worldwide.

Coinbase Ventures is the venture capital arm of Coinbase, established to support and invest in early-stage cryptocurrency and blockchain startups. Its mission is to advance the open financial system by backing founders who share Coinbase’s vision of creating more economic freedom for the world. The team partners with innovative teams at the forefront of crypto and Web3, providing capital, strategic guidance, and access to Coinbase’s ecosystem. The portfolio of Coinbase Ventures includes leading projects across various blockchain sectors, such as Layer 2 scaling solutions (Arbitrum, Optimism, Starkware), decentralized exchanges (Uniswap), NFT marketplaces (OpenSea, Magic Eden), blockchain analytics (Dune, Etherscan), and emerging Web3 social and data protocols (Farcaster, Zora, Vana). The firm is also actively involved in shaping the future of crypto infrastructure, including stablecoin payments, restaking, and AI-powered blockchain tools. Coinbase Ventures operates as a remote-first organization and is led by experienced professionals in venture capital and corporate development, maintaining a strong focus on supporting the global crypto ecosystem through strategic investments, thought leadership, and ecosystem-building initiatives.

CVS Health Ventures is the dedicated corporate venture capital arm of CVS Health established in 2021 to invest in and partner with high-potential, early-stage companies that align with CVS Health’s purpose of “bringing our heart to every moment of your health.”The fund focuses on technology‑enabled, consumer‑centric and value‑based healthcare solutions across care delivery, whole‑person care, consumer health and related health technologies, and leverages CVS Health’s national footprint and commercial channels to help portfolio companies scale and form business relationships with CVS business units.CVS Health Ventures launched with an initial allocation of $100 million for investments and combines capital with strategic support from CVS Health leadership and operating teams to accelerate adoption of innovative solutions that make care more accessible, affordable, and simpler for consumers.

Dell Technologies Capital (DTC) is the global venture capital arm of Dell Technologies, established in 2012. Headquartered in Palo Alto, with offices also in Boston and Tel Aviv, DTC has invested more than USD 1.7 billion in early-stage enterprise technology companies across the U.S., Europe, and Israel. Nine investments have led to public offerings, and over 85 portfolio companies have been acquired by tech leaders including Amazon, Apple, Cisco, Intel, Microsoft, VMware and Dell itself. DTC typically takes the lead in Seed and Series A funding rounds, taking board seats and offering more than capital. Their support includes customer introductions, market-fit coaching, pricing guidance, sales leadership mentoring, media support, and pipeline benchmarking. While backed by Dell Technologies, DTC operates as a financial returns-driven VC with performance consistently in the 95th percentile of early-stage investors. The firm targets transformative enterprise and infrastructure technologies—particularly in cybersecurity, artificial intelligence and machine learning, data analytics, edge and logistics, developer tools, silicon, and IoT. The team seeks technical founders with deep domain expertise and customer empathy who are building category-defining solutions. DTC remains actively deploying capital and leading rounds across its core geographies.

Figma Ventures is the corporate venture arm of Figma, created to support early-stage startups building innovative tools and technologies in the design, development, and collaborative software space. The initiative reflects Figma’s deep commitment to nurturing the next generation of companies that are transforming how teams create and build in a digital-first world. By investing in founders at the seed and pre-seed stages, Figma Ventures brings not only capital but also strategic mentorship and access to a rich ecosystem of designers, developers, and product builders. Its focus is on founders solving complex problems in creative workflows, infrastructure tooling, and the future of work. The firm places high value on creativity, open collaboration, and long-term impact. Figma Ventures operates with a founder-first philosophy, often investing in startups that align with Figma’s core mission of making design accessible and collaborative. Through its investments, the venture arm aims to extend its influence beyond design, enabling meaningful innovation across digital experiences and product creation.

Founded in 2019 and headquartered in Munich, Germany, Hitachi Ventures is the global corporate venture capital (CVC) arm of Hitachi Group. Operating as a standalone, return‑driven fund with Hitachi as its sole limited partner, the firm focuses on building partnerships with visionary founders to drive breakthrough innovation across climate, health, digital and industrial sectors. With offices in Munich, Boston and Palo Alto, Hitachi Ventures invests globally in startups aligned with Hitachi’s mission of social innovation. Under the leadership of CEO & Managing Director Dr. Stefan Gabriel—who founded the CVC and brings over 20 years of venture and corporate innovation experience—the firm invests in early to mid‑stage startups (primarily pre‑seed to Series B/C). Hitachi Ventures provides both capital and strategic alignment with Hitachi’s business units, enabling collaboration and scale opportunities across industry, digital, environment and healthcare domains. The firm currently manages four funds, including Fund IV launched in February 2025 with a commitment of $400 million, bringing total assets under management to approximately $1 billion. Hitachi Ventures seeks startups primarily in Europe, Israel and North America, targeting areas like Industry 5.0, TechBio, AI/data infrastructure, circular economy solutions, decarbonization and frontier deep‑tech.

Intel Capital, established in 1991 as the investment arm of Intel Corporation, is a pioneering corporate venture capital firm dedicated to advancing the future of computing. Over three decades, it has invested more than $20 billion in over 1,800 companies worldwide, focusing on strategic equity investments that support Intel’s ecosystem and foster innovation across multiple technology domains. Intel Capital spun off as a standalone investment fund, continuing its mission with greater independence while maintaining strong ties to Intel.The firm invests primarily in early-stage startups and growth companies across four key areas of the technology ecosystem: Cloud, Devices, Frontier (including quantum computing and AI), and Silicon. Intel Capital leverages Intel’s resources by placing over 200 Embedded Experts within portfolio companies and facilitating more than 1,300 curated introductions to Global 2000 customers annually, helping startups scale and succeed in competitive markets.Intel Capital’s portfolio includes notable investments in artificial intelligence, autonomous technology, semiconductor manufacturing, cybersecurity, and next-generation compute infrastructure. The firm has a strong track record with over 700 portfolio exits and has created over $170 billion in market value in the last decade. Its global investment footprint spans North America, Western Europe, Israel, and Asia Pacific, reflecting a comprehensive approach to fostering innovation worldwide.

Koch Disruptive Technologies (KDT) is the venture capital arm of Koch, Inc., founded in November 2017 and led by Chase Koch. With an ethos rooted in “creative destruction,” KDT partners with principled entrepreneurs building transformative platforms that can both elevate Koch’s core capabilities and open entirely new industrial frontiers. KDT invests across a wide spectrum of high-growth sectors including healthcare, supply-chain & manufacturing, cybersecurity, fintech, semiconductors, connectivity, enterprise software, and energy transformation. It leverages internal resources through its Koch Labs network, offering portfolio companies access to Koch’s global expertise in logistics, IT, manufacturing, and more, creating mutual benefit and accelerating growth. The firm has committed over US $4 billion to disruptive enterprise-technology ventures, and maintains a strategic focus on long-term partnerships that benefit both entrepreneurs and Koch’s ecosystem. Recent lead investments include Insightec’s $150 million Series E in medical technology and Optimal Dynamics’ $40 million Series C in AI-driven logistics software.

Labcorp Venture Fund is the strategic investment arm of Labcorp, a global life sciences and diagnostics company. The fund is dedicated to supporting innovative startups in the healthcare and biotechnology sectors that align with Labcorp’s mission to improve health and improve lives. By investing in early-stage companies, the fund helps foster breakthroughs in diagnostics, drug development, digital health, and personalized medicine. The Labcorp Venture Fund provides both financial backing and strategic resources, including access to Labcorp’s extensive R&D capabilities, clinical trial infrastructure, and commercial channels. This strategic alignment allows portfolio companies to scale effectively and accelerate the impact of their solutions in the healthcare market. The fund targets investments that complement Labcorp’s core services while also exploring emerging opportunities in health technology and therapeutics. With a selective and collaborative investment approach, the Labcorp Venture Fund plays a critical role in advancing innovation across the healthcare value chain.

LG Technology Ventures is the corporate venture capital (CVC) arm of LG Group, established in 2018 and headquartered in Silicon Valley, California. The firm specializes in identifying and investing in innovative startups at the forefront of technology, with a strategic focus on sectors such as artificial intelligence, biotechnology, cleantech, advanced materials, and mobility. By leveraging the global resources and expertise of LG Group, LG Technology Ventures provides not only capital but also access to strategic partnerships, industry knowledge, and operational support for its portfolio companies. The firm partners with early- and growth-stage companies worldwide, aiming to drive innovation and create value for both startups and LG affiliates. LG Technology Ventures has built a robust portfolio of over 80 active investments and has facilitated more than 10 exits or IPOs. Its investments span a wide range of industries, including AI, biotech, energy, batteries, healthcare, and advanced materials. Notable portfolio companies include Anthropic, Arcellx, Inworld AI, Figure AI, and OTI Lumionics. The team consists of experienced investors, entrepreneurs, technologists, and industry experts who work closely with founders to help them scale and succeed. LG Technology Ventures is committed to fostering long-term relationships with its portfolio companies, offering strategic guidance, access to LG’s global network, and support in navigating complex market dynamics. The firm’s approach emphasizes founder-centricity, aiming to help startups overcome challenges in talent acquisition, sales strategy, and organizational development. With a strong track record of successful investments and exits, LG Technology Ventures continues to play a pivotal role in shaping the future of technology and innovation.

M12 is the corporate venture arm of Microsoft, focused on empowering early-stage companies to scale with the backing of one of the world’s leading technology firms. Founded in 2016, M12 strategically invests in enterprise startups that align with Microsoft’s mission to enable digital transformation across industries. With a keen interest in cloud infrastructure, artificial intelligence, and cybersecurity, M12 partners with visionary founders who are building the next generation of enterprise technologies. Beyond capital, M12 provides portfolio companies with unmatched access to Microsoft’s vast technical resources, global customer network, and go-to-market support. The fund operates with a founder-first approach, emphasizing strategic guidance, industry mentorship, and long-term collaboration. Through this approach, M12 enhances the growth trajectory of its investments and fosters innovation at the edge of enterprise advancement. Headquartered in San Francisco with offices in Seattle, London, and Tel Aviv, M12 maintains a global footprint. This enables the firm to identify high-potential startups in key innovation hubs and help them scale internationally. As a sector-agnostic investor with a technology-first lens, M12 continues to play a significant role in shaping the enterprise ecosystem of the future.

Next47, founded in 2016 as a wholly owned subsidiary of Siemens AG, is a global venture capital firm dedicated to partnering with visionary enterprise founders to develop groundbreaking products and technologies. Leveraging Siemens’ extensive global footprint and technical expertise, Next47 supports startups across the entire venture lifecycle, from incubation to growth and exit. The firm operates major offices in innovation hubs including Palo Alto, Munich, Berlin, London, Tel Aviv, Paris, and Shanghai.Next47 focuses on investing in B2B startups in enterprise technology sectors such as SaaS, IT infrastructure, and industrial technology including manufacturing, construction, proptech, energy, transportation, logistics, and supply chain. Its investment philosophy emphasizes early-stage ventures with high growth potential, combining financial discipline with hands-on operational support. The firm’s unique dual-team structure balances investment decisions with go-to-market execution, enabling portfolio companies to scale effectively.Backed by approximately €1 billion in funding over five years, Next47 has invested over €800 million in more than 180 startups globally. The firm’s portfolio includes 239 companies with 14 unicorns, spanning North America, Europe, Israel, and other key markets. Next47’s approach prioritizes financial returns while leveraging Siemens’ ecosystem to provide strategic value without imposing corporate constraints, positioning it as a leading corporate venture capital firm competing with top-tier independent VCs.

Northwestern Mutual Future Ventures is the corporate venture capital arm of Northwestern Mutual, a Milwaukee-based financial services mutual company. Launched in 2016 with an initial fund size of $50 million, it has grown to manage over $300 million in assets, focusing on early-stage startups that transform consumer finance, health, and technology experiences. The firm pursues both financial returns and strategic partnerships. It has achieved five exits and activated collaborations with over a third of its portfolio companies. Led by a five-person team, including Chief Commercial Officer Aditi Javeri Gokhale and Managing Director Craig Schedler, the Ventures group typically invests between $500K and $5M per deal in areas like financial technology, insurtech, wealth management technology, healthcare, data analytics, and AI solutions. As the center of expertise within Northwestern Mutual for emerging technologies, the firm supports its portfolio companies through sustained funding, quarterly business reviews, and entrepreneur growth, co-investing with other VCs when aligned opportunities arise. Northwestern Mutual Future Ventures is also committed to impact investing, aimed at expanding financial access for underserved entrepreneurs and communities via support programs such as mentorship and training. Portfolio examples include companies like Trust and Will, which offers estate planning services, and Alkymi, focused on AI-driven middle office solutions. This aligns with the firm’s broader goals of enhancing advisor tools, improving client experiences, and advancing health data analytics.

NVIDIA Ventures is the corporate venture capital arm of NVIDIA Corporation, a global leader in accelerated computing and artificial intelligence. With a focus on identifying and investing in startups that align with NVIDIA’s long-term vision, the venture arm supports early-stage companies that are building groundbreaking technologies in AI, deep learning, data science, and high-performance computing. The firm strategically invests in startups that complement NVIDIA’s core technologies, including AI platforms, autonomous systems, graphics, simulation, healthcare computing, and robotics. NVIDIA Ventures brings more than capital to the table—it offers technical collaboration, go-to-market support, and access to a global developer and enterprise ecosystem. Operating globally, NVIDIA Ventures seeks to accelerate innovation by fostering partnerships that push the boundaries of what’s possible in technology. The venture team plays a critical role in NVIDIA’s strategy to empower industries such as healthcare, automotive, enterprise AI, and scientific research through next-gen computing solutions.

Pfizer Ventures is the venture capital arm of Pfizer Inc., one of the world’s leading biopharmaceutical companies. Established to identify and invest in early-stage companies that align with Pfizer’s long-term strategy, Pfizer Ventures focuses on accelerating innovation in areas such as drug discovery, therapeutics, diagnostics, and healthcare technologies. The firm manages a dedicated investment portfolio, supporting biotech startups that are developing groundbreaking science and technologies across oncology, immunology, neuroscience, rare diseases, and digital health. Pfizer Ventures offers more than just capital; it brings deep scientific expertise, commercial insight, and access to Pfizer’s global network of R&D and business leaders. With an active presence in North America, Europe, and selected international markets, Pfizer Ventures seeks to foster partnerships that not only yield financial returns but also contribute to Pfizer’s overarching goal of delivering breakthroughs that change patients’ lives. The team operates with a collaborative, long-term mindset that supports companies from early development through commercialization.

Prebys Ventures is the venture capital arm of the Conrad Prebys Foundation, established to drive innovation and economic growth within the San Diego region. Launched in 2025 with a $50 million fund, it focuses on investing in early and growth-stage technology and healthcare companies based in San Diego. The fund aims to address a critical resource gap in the local innovation ecosystem by partnering with leading venture firms and leveraging a robust network of domain experts and exited CEOs. The fund operates with a unique financial model that reinvests returns back into the San Diego economy to create a sustainable, perpetually growing investment vehicle. Prebys Ventures seeks to support companies with a venture-capital growth model, typically investing between $500,000 and $2 million per round, and often taking board observer seats to actively support portfolio companies through strategic guidance and network access. Prebys Ventures is led by Managing Director Mike Krenn, a seasoned San Diego innovation community leader with a track record of raising over $800 million for regional startups. The fund’s mission is to fuel lasting economic opportunity and a thriving San Diego community by investing in companies that align with the foundation’s focus on health, research, and innovation, thereby strengthening San Diego’s position as a global innovation hub.